Status:
COMPLETED
Asparagus Capsule Consumption and Blood Sugar and Lipids and Oxidative Stress
Lead Sponsor:
Burapha University
Conditions:
Asparagus Capsule Consumption
Eligibility:
All Genders
18-59 years
Phase:
PHASE2
Brief Summary
Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules and 21 placebo capsules groups. They re...
Detailed Description
The study design was cross-sectional. Participants were 44 overweight and obese persons, male and female, age 18-59 years. Participants were divided into 2 groups consisting of 23 asparagus capsules a...
Eligibility Criteria
Inclusion
- Man or woman, aged between 18 to 59 years
- Body mass index more than 23 (Asian criteria)
- No history of hypertension, diabetes, cardiovascular disease, respiratory disease, endocrine disease, neuromuscular disease, musculoskeletal disease, liver disease, renal disease, immune disease, infectious disease, or cancer
- No regular intake of dietary supplements, i.e., vitamins, antioxidants
- No regular smokers or alcohol drinkers (\>2 times per week)
- Not sportman or regular exerciser (\>2 times per week or \>150 min per week)
- No food allergy, especially shoot
Exclusion
- \- Current signs or symptoms of infection, i.e., fever, hyperpnea, dyspnea, and palpitations.
Key Trial Info
Start Date :
December 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 14 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06195813
Start Date
December 20 2022
End Date
September 14 2023
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Allied Health Sciences, Burapha University
Mueang, Changwat Chon Buri, Thailand, 20131